Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
BIO-key International announced a warrant inducement transaction with an institutional investor involving the exercise of warrants to purchase 618,334 shares at a reduced price, generating approximately $2.5 million in gross proceeds. In return, the company will issue new unregistered warrants subject to stockholder approval, enhancing its capital …
Cingulate Inc. announced the publication of peer-reviewed pharmacokinetic data for CTx-1301, its lead ADHD treatment candidate. The study shows that CTx-1301 delivers a unique trimodal release of dexmethylphenidate, offering rapid onset and sustained medication coverage throughout the active day with fewer adverse events than existing treatments. T…
Conexeu Sciences Inc., a Nasdaq-listed preclinical-stage biotech company that develops extracellular matrix-based tissue restoration technologies, announced that its Chief Medical Officer, Dr. Brian Pilcher, will present at the 2026 Controversies & Conversations in Laser & Cosmetic Surgery Symposium. The presentation covers the company's novel ECM …
NeoVolta Inc., a U.S.-based energy storage technology company, announced its participation schedule for upcoming investor conferences taking place virtually and in-person during August and September 2026. Management will engage in one-on-one meetings to discuss company progress and developments, including updates on its new manufacturing facility.
Intelligent Bio Solutions has completed its multi-site Method Comparison Study for its Intelligent Fingerprinting Drug Screening System, a significant milestone for its FDA 510(k) submission targeting U.S. market clearance for opiate detection. The study, conducted across three U.S. clinical sites with a diverse participant base, demonstrated the s…
SurgePays, a US-based wireless and fintech company, reported significant growth in its smartphone rent-to-own program with LowWeeklyPayments, hitting $176,000 in retail sales for July, a 23% increase from June. The program, targeting subprime consumers, shows strong potential to become a distinct revenue channel and is under consideration for expan…
PDS Biotechnology Corporation announced a strategic prioritization of its tumor-targeted immunocytokine PDS0301, focusing on its advancement in metastatic colorectal cancer and other solid tumors, while seeking partnerships for the continued development of PDS0101. The company highlights encouraging Phase 2 clinical data for PDS0301, especially in …
Mereo BioPharma reported a net loss reduction in Q2 2026 compared to Q2 2025, extended cash runway into late 2027, and entered a key option and license agreement with Sentynl Therapeutics for alvelestat, targeting alpha-1 antitrypsin deficiency-associated lung disease. The company is engaging with regulators on setrusumab for osteogenesis imperfect…
Astrotech Corporation announced that its subsidiary, Lunar Power and Light Corporation (LP&L), intends to develop a commercial lunar electric utility to provide continuous power on the lunar surface using solar towers and battery storage. The initiative aims to serve various lunar operations including construction, data centers, mining, and robotic…
Catheter Precision, Inc.'s subsidiary Flyte announced a strategic partnership with The Nucleus Network to support their inaugural flagship founder and investor event. This collaboration highlights Flyte's commitment to embedding itself within the entrepreneurial and venture capital ecosystem through networking and relationship-building. Flyte aims …
Howard Hughes Holdings Inc. announced that its 2026 Annual Shareholder Meeting will be held on September 30, 2026, in New York City. The meeting will feature presentations from key executives, including updates on company strategy, business priorities, and long-term growth initiatives. Shareholders will have the opportunity to engage in a Q&A sessi…
Clearmind Medicine announced successful results from a permeation study of its proprietary intranasal MEAI formulation, showing enhanced nasal residence time without compromising drug delivery. The formulation maintains effective permeation rates comparable to conventional solutions while significantly extending nasal retention, which supports its …
Teva Pharmaceutical Industries Ltd. announced that Moody's Ratings has upgraded its corporate credit rating to Baa3 from Ba1, achieving investment-grade status with a stable outlook. This upgrade reflects Teva's successful execution of its Pivot to Growth strategy, including revenue diversification, improved operating margins, debt reduction, and a…
Anavex Life Sciences Corp. filed its definitive proxy materials for the upcoming 2026 Annual Meeting, urging stockholders to vote for its six highly qualified, independent director nominees. The company highlights recent leadership changes to stabilize operations and advance its CNS-focused drug development programs, particularly the oral blarcames…
Incannex Healthcare Inc., a clinical-stage biopharmaceutical company listed on Nasdaq, announced receipt of an additional A$5.1 million R&D tax incentive refund from the Australian Government. This completes over A$11.2 million received in 2026 as non-dilutive capital, enhancing the company's cash position and debt-free balance sheet to support adv…
Hanmi Financial Corporation, a NASDAQ-listed financial institution serving multi-ethnic communities through its subsidiary Hanmi Bank, announced its participation in the D.A. Davidson 16th Annual Western Bank Summit on August 11-12, 2026. The company's CEO and CFO will engage with institutional investors during virtual meetings. The event aims to p…
Village Farms International announces the introduction of easy-pour pouches for its Super Toast brand's milled cannabis flower, marking the first use of this packaging format in Canada. The innovation features a convenient spout, color-coded caps, and a window to view product freshness. Super Toast has become a leading national brand in Canada, wit…
IMUNON, Inc. announced its second quarter 2026 financial results and provided an update on the development of its lead DNA-based immunotherapy candidate, IMNN-001, for newly diagnosed advanced ovarian cancer. The company highlighted accelerated enrollment in the pivotal Phase 3 OVATION 3 trial, promising Phase 2 data showing significant overall sur…
AXIL Brands, Inc., a consumer products company specializing in hearing protection and hair and skin care products, plans to release its fiscal Q4 and full year 2026 earnings on August 18, followed by a conference call for a corporate update and Q&A with investors.
Adamas Trust, Inc., a U.S.-based REIT listed on Nasdaq, announced an 11.1% increase in its quarterly common stock dividend from $0.27 to $0.30 per share for the quarter ending September 30, 2026. The dividend payment is scheduled for October 28, 2026. CEO Jason Serrano highlighted the dividend increase as a reflection of the company’s strong earnin…
CN announced a record movement of over 33.8 million metric tonnes of grain from Western Canada during the 2025-26 crop year, surpassing the previous year's record. This growth was driven by strong customer demand and operational efficiency. CN also released its 2026-27 Grain Plan aimed at further supporting the grain supply chain in the upcoming ha…
Mereo BioPharma has partnered with Sentynl Therapeutics to grant Sentynl exclusive US commercialization and global manufacturing rights for alvelestat, an investigational oral treatment for Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD). The agreement includes upfront payments, milestone potential up to $435 million, and royalties…
Abundia Global Impact Group, Inc. announced significant progress in its commercialization strategy during Q2 2026, including the acquisition and integration of RPD Technologies, expansion of its Cedar Port facility, and securing strategic partnerships such as with Topsoe and Burns & McDonnell. The company increased revenue to $2 million for the qua…
YD Bio Limited announced the launch of two physician-partnered chrono-nutrition nutraceutical formulations in Taiwan, developed collaboratively with the Taiwan Chronic Disease Healthcare Association and the Future Health Institute. This initiative marks the company's first step in building a repeatable physician-partnership ecosystem aimed at meeti…
Protara Therapeutics announced its second quarter 2026 financial results and provided updates on its clinical pipeline, including enrollment progress in its ADVANCED-2 and STARBORN-1 trials, and the redesign of the ADVANCED-3 trial to broaden data collection in non-muscle invasive bladder cancer. The company anticipates submitting a Biologics Licen…
